Speaker: Rizka Ayu Setyani
Facilitator: Terri Downer and Scarlet Woolcott
One of the obstacles to handling HIV is late diagnosis due to a lack of access to diagnostic services in health facilities. In addition, the negative stigma against this disease also makes people reluctant to diagnose at health facilities. Early diagnosis needs to be done, especially in pregnant women, as an essential condition that needs to be known in childbirth and breastfeeding. Unfortunately, the HIV testing policy in Indonesia still has loopholes for the mother or the patient to refuse to take the HIV test. Health workers are required to offer HIV testing, but the mother’s voluntary willingness determines the HIV test. This implementation trial pilot study used random cluster sampling to select seven intervention and seven control sites in Yogyakarta city, Indonesia. Seven intervention health facilities used the EKSTRIM website for three months, from January through April 2022, to educate and do HIV counselling with pregnant women patients. EKSTRIM website was designed for use on mobile phones to improve HIV testing among pregnant women. Health workers managed to record 1,594 visits and were able to increase HIV testing by 6.7% in pregnant women. The EKSTRIM pilot demonstrated the feasibility of implementing a digital healthcare-integrated solution in a low-resource setting, health worker capacity building and patient self-care into a single robust and responsive system. Although the implementation phase was only three months, the pilot generated evidence that EKSTRIM could increase HIV testing uptake.
Recording: https://youtu.be/tG1Vs6rwvHQ
Speaker: Patricia Marianella
Facilitator: Paloma Terra
El objetivo fue comparar los resultados materno-neonatales y costos de la resolución de embarazos, en mujeres obesas y con peso normal pregestacional.
Métodos: Estudio transversal realizado en 60 gestantes con obesidad y 120 con peso normal pregestacional atendidas en un hospital público de Lima durante el 2018, seleccionadas aleatoriamente. Se recolectaron datos sociodemográficos, indicadores maternos (índice de masa corporal pregestacional, controles prenatales, edad gestacional, días de hospitalización), neonatales (Apgar, peso, morbilidad, edad gestacional por examen físico, días de hospitalización) y datos de los costos (medicamentos, procedimientos e insumos). Se utilizó la prueba estadística U de Mann Whitney.
Resultados: Se encontraron diferencias entre mujeres obesas y con peso normal pregestacional en los días de hospitalización materna (3 ±1,2 días vs 2,0 ±1,2 días; p=0,000); en el peso del recién nacido (3 615 ± 518,03 gr vs 3 245 ± 426,25 gr; p=0,000), en el costo de medicamentos ($ 19,78 ±16,47 vs $ 3,21 ±15,57; p=0,000), en el costo de procedimientos ($ 40,65 ±46,78 vs $ 27,67 ±49,47; p=0,001), y en el costo de insumos ($ 54,08 ±29,02 vs $ 9,32 ±28,26; p=0,000).
Conclusión: Las mujeres obesas presentaron recién nacidos con mayor peso, contaron con más días de hospitalización y los costos de medicamentos, procedimientos e insumos fueron superiores en comparación con las mujeres de peso normal.
English:
The objective was to compare maternal-neonatal outcomes and costs of pregnancy resolution in obese women and women with normal pregestational weight. Methods: Cross-sectional study conducted in 60 pregnant women, randomly selected, with obesity and 120 with normal pregestational weight attended in a public hospital in Lima during 2018. Sociodemographic data, maternal indicators (pregestational body mass index, prenatal controls, gestational age, days of hospitalization), neonatal (Apgar, weight, morbidity, gestational age by physical examination, days of hospitalization) and cost data (drugs, procedures and supplies) were collected. The Mann Whitney U statistical test was used. Results: Differences were found between obese and pregestational normal weight women in maternal hospitalization days (3 ±1.2 days vs. 2.0 ±1.2 days; p=0.000); in newborn weight (3 615 ± 518.03 gr vs. 3 245 ± 426.25 gr; p=0.000), in the cost of medications ($ 19.78 ±16.47 vs $ 3.21 ±15.57; p=0.000), in the cost of procedures ($ 40.65 ±46.78 vs $ 27.67 ±49.47; p=0.001), and in the cost of supplies ($ 54.08 ±29.02 vs $ 9.32 ±28.26; p=0.000).Conclusion: Obese women had heavier newborns, more days of hospitalization and the costs of medications, procedures and supplies were higher compared to women of normal weight.
Recording: https://youtu.be/McAV7M1Ub4M
